Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)	Indolent B-cell Non-Hodgkin's Lymphoma	Active, not recruiting	Phase 2	2026-10-05		NCT04533581

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Kyowa Kirin Co., Ltd.	15

30 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aichi Cancer Center Hospital	Nagoya	Japan	4
Akita University Hospital	Akita	Japan	1
Anjo Kosei Hospital	Anjo	Japan	2
Aomori Prefectural Central Hospital	Aomori	Japan	2
Chiba Cancer Center	Chiba	Japan	4
Chugoku Central Hospital	Fukuyama	Japan	1
Gunma University Hospital	Maebashi	Japan	11
Hokkaido University Hospital	Sapporo	Japan	10
Ishikawa Prefectural Central Hospital	Kanazawa	Japan	2
Japanese Red Cross Kyoto Daini Hospital	Kyoto	Japan	5
Japanese Red Cross Nagoya Daini Hospital	Nagoya	Japan	1
Jichi Medical University Hospital	Shimotsuke	Japan	3
Kagoshima University Hospital	Kagoshima	Japan	8
Kameda Medical Center	Kamogawa	Japan	2
Kindai University Hospital	Sayama	Japan	4
Kurashiki Central Hospital	Kurashiki	Japan	3
Kyushu University Hospital	Fukuoka	Japan	20
Mie University Hospital	Tsu	Japan	7
National Cancer Center Hospital	Chuo-ku	Japan	17
National Hospital Organization Kumamoto Medical Center	Kumamoto	Japan	3
National Hospital Organization Kyushu Medical Center	Fukuoka	Japan	4
National Hospital Organization Nagoya Medical Center	Nagoya	Japan	1
National Hospital Organization Shikoku Cancer Center	Matsuyama	Japan	3
Okayama University Hospital	Okayama	Japan	21
Osaka University Hospital	Suita	Japan	5

Clinical trials